9/12/2024  8:01:34 AM Chg. +4.7000 Volume Bid8:10:55 AM Ask8:10:55 AM Market Capitalization Dividend Y. P/E Ratio
176.5000EUR +2.74% 0
Turnover: 0.0000
176.4000Bid Size: 30 176.7600Ask Size: 30 11.33 bill.EUR - -

Business description

Cochlear is the global leader in implantable hearing solutions. It has a dedicated global team of more than 2,700 people who deliver the gift of sound to those with hearing loss in over 100 countries. Its vision is to connect people, young and old, to a world of sound by offering life enhancing hearing solutions. The Cochlear promise of "Hear now. And always" embodies the company's commitment to providing its recipients with their best possible hearing performance today and for the rest of their lives. For over 30 years Cochlear has helped hundreds of thousands of people either hear for the first time or reconnect them to their families, friends, workplaces and communities.
 

Management board & Supervisory board

CEO
Dig Howitt
Management board
Stuart Sayers, Jan Janssen, Lisa Aubert, Richard Brook, Anthony Bishop, Dean Phizacklea, Karen O’Driscoll, Greg Bodkin, Jennifer Hornery, Brian Kaplan, Rob McGrory
Supervisory board
Alison Deans, Dig Howitt, Glen Boreham, Michael Daniell, Michael del Prado, Andrew Denver, Christine McLoughlin, Karen Penrose, Bruce Robinson
 

Company data

Name: Cochlear Limited
Address: 1 University Avenue, Macquarie University,Sydney NSW 2109, Australia
Phone: +61-2-9428-6555
Fax: +61-2-9428-6352
E-mail: -
Internet: www.cochlear.com/au
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 6/30
Free Float: -
IPO date: -

Investor relations

Name: -
IR phone: +61 1300 850 505
IR Fax: -
IR e-mail: web.queries@computer....com.au web.queries@computershare.com.au

Company calendar

CW 38 | 9/17/2024 Ex-Dividend
CW 38 | 9/18/2024 Record Date
CW 41 | 10/10/2024 Dividend Payment
CW 43 | 10/25/2024 General Shareholder Meeting
CW 7 | 2/14/2025 Interim Report 2nd Quarter/6 Months